• SENSEX 76,790.47
    220.12 (+0.29%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
Back

Corporate News

Cipla’s Aspergen joint venture acquires 100% stake in Aspergen Inc., USA
27-Aug-2026, 08:59

Cipla Ltd. announced that Aspergen Limited, a 60:40 joint venture with Kemwell Biopharma Private Limited, has acquired 100% stake in Aspergen Inc., USA, from Cipla (EU) Limited and Kemwell Biopharma UK Limited, making Aspergen Inc., USA a wholly owned subsidiary of Aspergen Limited, India; the restructuring was undertaken to rationalize and simplify the group structure and results in no change to Cipla’s economic interest in Aspergen Inc., USA.